Open Access

Erratum To: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy

  • Heng Li1,
  • Gan Yu1,
  • Runlin Shi1,
  • Bin Lang3,
  • Xianguo Chen4,
  • Ding Xia1,
  • Haibing Xiao1,
  • Xiaolin Guo1,
  • Wei Guan1,
  • Zhangqun Ye1,
  • Wei Xiao2Email author and
  • Hua Xu1Email author
Contributed equally
Molecular Cancer201413:183

https://doi.org/10.1186/1476-4598-13-183

Received: 5 August 2014

Accepted: 5 August 2014

Published: 14 August 2014

The original article was published in Molecular Cancer 2014 13:8

Correction

After the publication of this work [1] it was brought to the authors’ attention that Figures six (Figure 1 here) (E) and (F) contained an error in their data presentation. The correct figure is given below.
Figure 1

The tumor-suppressive and chemosensitivity functions of miR-34a were mediated by reduction the production of CD44. Downregulation of CD44 by siRNA led to similar effect of miR-34a overexpression on A) cell proliferation (mean ± SEM; n = 3; *p < 0.05) and B-C) tumorigenity (mean + SEM; n = 3; *p < 0.05). Increased CD44 expression could efficiently reverse the effect of miR-34a on MIBC D) cell proliferation (mean ± SEM; n = 3; *p < 0.05), E-F) colongenic potential and G) chemosensitivity (mean + SEM; n = 3; *p < 0.05).

We regret any inconvenience that this inaccuracy may have caused.

Notes

Declarations

Authors’ Affiliations

(1)
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
(2)
Translational Medicin Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
(3)
School of Health Sciences, Macao Polytechnic Institute
(4)
Department of Urology, First Affiliated Hospital of Anhui Medical University

References

  1. Heng L, Gan Y, Runlin S, Bin L, Xianguo C, Ding X, Haibing X, Xiaolin G, Wei G, Zhangqun Y, Wei X, Hua X: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Molecular Cancer. 2014, 13: 8- 10.1186/1476-4598-13-8View ArticleGoogle Scholar

Copyright

© Li et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement